reboxetine has been researched along with Chronic Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ampuero, E; Cavada, G; Diaz-Veliz, G; Luarte, A; Rubio, FJ; Santibañez, M; Toledo, J; Varas-Godoy, M; Wyneken, U | 1 |
| Beltran, E; Domínguez-Andrés, J; Erburu, M; Mai, A; Muñoz-Cobo, I; Puerta, E; Suzuki, T; Tordera, RM; Valente, S | 1 |
| Fontenelle, LF; Mendlowicz, MV; Miguel, EC; Versiani, M | 1 |
| Liepert, J; Weiller, C; Zittel, S | 1 |
| Berk, M; Schutz, G | 1 |
2 trial(s) available for reboxetine and Chronic Disease
| Article | Year |
|---|---|
Reboxetine improves motor function in chronic stroke. A pilot study.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Analysis of Variance; Chronic Disease; Double-Blind Method; Female; Functional Laterality; Hand Strength; Humans; Male; Middle Aged; Morpholines; Physical Therapy Specialty; Pilot Projects; Psychomotor Performance; Reboxetine; Severity of Illness Index; Stroke; Stroke Rehabilitation; Transcranial Magnetic Stimulation | 2007 |
Reboxetine add on therapy to haloperidol in the treatment of schizophrenia: a preliminary double-blind randomized placebo-controlled study.
Topics: Adult; Antidepressive Agents; Chronic Disease; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2001 |
3 other study(ies) available for reboxetine and Chronic Disease
| Article | Year |
|---|---|
Two Chronic Stress Models Based on Movement Restriction in Rats Respond Selectively to Antidepressant Drugs: Aldolase C As a Potential Biomarker.
Topics: Animals; Antidepressive Agents; Chronic Disease; Depressive Disorder; Disease Models, Animal; Fluoxetine; Fructose-Bisphosphate Aldolase; Green Fluorescent Proteins; Male; Morpholines; Rats, Sprague-Dawley; Reboxetine; Restraint, Physical; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Stress, Psychological | 2015 |
Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity.
Topics: Adult; Animals; Antidepressive Agents; Chronic Disease; Depressive Disorder; Fluoxetine; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Imipramine; Male; Mice, Inbred C57BL; Middle Aged; Morpholines; Neuronal Plasticity; Prefrontal Cortex; Reboxetine; RNA, Messenger; Sirtuins; Stress, Psychological | 2015 |
Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Citalopram; Drug Resistance; Drug Therapy, Combination; Humans; Male; Morpholines; Obsessive-Compulsive Disorder; Reboxetine; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2005 |